Structured evidence table for Cinnamon Metabolic Health Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Cinnamon Metabolic Health Meta-Analysis | Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) affect adults worldwide and are causes of morbidity. | 1 | Chen Liang A (2026) | Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis. |
| Cinnamon Metabolic Health Meta-Analysis | Evidence synthesis has been limited by heterogeneity in formulations and study quality. | 1 | Chen Liang A (2026) | Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis. |
| Cinnamon Metabolic Health Meta-Analysis | Risk of bias was assessed using RoB 2.0, and certainty of evidence using Confidence in NMA. | 1 | Chen Liang A (2026) | Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis. |
| Cinnamon Metabolic Health Meta-Analysis | While lifestyle modification remains in first-line therapy, interest has emerged in herbal agents with potential hepatometabolic effects. | 1 | Chen Liang A (2026) | Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis. |
| Cinnamon Metabolic Health Meta-Analysis | Type 2 diabetes is associated with altered microbial composition, reduced butyrate-producing taxa and disrupted metabolic pathways. | 4 | Okonta EO (2026) | The gut microbiome as a plausible but unproven moderator of cinnamon trial outcomes in type 2 diabetes: toward phytochemical standardization and precision nutraceuticals. |
| Cinnamon Metabolic Health Meta-Analysis | Cinnamon ( Cinnamomum spp.) has been widely investigated as an adjunctive nutraceutical for glycemic management in type 2 diabetes mellitus, yet clinical findings remain inconsistent. | 4 | Okonta EO (2026) | The gut microbiome as a plausible but unproven moderator of cinnamon trial outcomes in type 2 diabetes: toward phytochemical standardization and precision nutraceuticals. |
| Cinnamon Metabolic Health Meta-Analysis | This variability is commonly attributed to differences in cinnamon species, dosage, intervention duration, baseline glycemic status and phytochemical standardization, alongside methodological factors such as trial quality, dietary patterns, medication use, adherence and endpoint selection. | 4 | Okonta EO (2026) | The gut microbiome as a plausible but unproven moderator of cinnamon trial outcomes in type 2 diabetes: toward phytochemical standardization and precision nutraceuticals. |
Source documents